Sun exposure, vitamin D intake and progression to disability among veterans with progressive multiple sclerosis

Neuroepidemiology

Volumn 37, Issue 1, 2011, Pages 52-57

  McDowell, Tzu Yun ^a,b   Amr, Sania ^b   Culpepper, William J ^a,c   Langenberg, Patricia ^b   Royal, Walter ^a,b   Bever, Christopher ^a,b   Bradham, Douglas D ^a,d  

^a BALTIMORE VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

Author keywords

Disability; Multiple sclerosis; Progression; Sun exposure; Vitamin D

Indexed keywords

COD LIVER OIL; VITAMIN D;

ADOLESCENCE; ADULT; AGE DISTRIBUTION; ARTICLE; AUTUMN; CHILDHOOD; DIET SUPPLEMENTATION; DISABILITY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; REGISTER; RISK ASSESSMENT; SUN EXPOSURE; VETERAN; VITAMIN INTAKE; WINTER;

AGED; COD LIVER OIL; DISABILITY EVALUATION; DISABLED PERSONS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; QUESTIONNAIRES; RISK; SUNLIGHT; VETERANS; VITAMIN D;

EID: 79961101734     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000329258     Document Type: Article

References (30)

1. Van Amerongen BM, Dijkstra CD, Lips P, Polman CH: Multiple sclerosis and vitamin D: An update. Eur J Clin Nutr 2004; 58: 1095-1109. (Pubitemid 39172383)
2. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A: Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838. (Pubitemid 44969183)
3. Van der Mei IA, Ponsonby AL, Dwyer T, et al: Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case-control study. BMJ 2003; 327: 316.
4. Kampman MT, Wilsgaard T, Mellgren SI: Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 2007; 254: 471-477. (Pubitemid 46786722)
5. Islam T, Gauderman WJ, Cozen W, Hamilton AS, Burnett ME, Mack TM: Differential twin concordance for multiple sclerosis by latitude of birthplace. Ann Neurol 2006; 60: 56-64.
6. Cantorna MT, Hayes CE, De Luca HF: 1,25-Dihydroxyvitamin D 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 1996; 93: 7861-7864. (Pubitemid 26277129)
7. Lemire JM, Archer DC: 1,25-dihydroxyvitamin D 3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 1991; 87: 1103-1107.
8. Muthian G, Raikwar HP, Rajasingh J, Bright JJ: 1,25 Dihydroxyvitamin-D 3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res 2006; 83: 1299-1309. (Pubitemid 43668013)
9. Van Etten E, Branisteanu DD, Overbergh L, Bouillon R, Verstuyf A, Mathieu C: Combination of a 1,25-dihydroxyvitamin D 3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone. Bone 2003; 32: 397-404. (Pubitemid 36407540)
10. Nashold FE, Hoag KA, Goverman J, Hayes CE: Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D 3 prevention of experimental autoimmune encephalomyelitis. J Neuroimmunol 2001; 119: 16-29. (Pubitemid 32781724)
11. Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC: Timing of birth and risk of multiple sclerosis: Population based study. BMJ 2005; 330: 120.
12. Sadovnick AD, Duquette P, Herrera B, Yee IM, Ebers GC: A timing-of-birth effect on multiple sclerosis clinical phenotype. Neurology 2007; 69: 60-62. (Pubitemid 47025205)
13. Tremlett HL, Devonshire VA: Does the season or month of birth influence disease progression in multiple sclerosis? Neuroepidemiology 2006; 26: 195-198. (Pubitemid 43876721)
14. McDowell TY, Amr S, Langenberg P, Royal W, Bever C, Culpepper WJ, Bradham DD: Time of birth, residential solar radiation and age at onset of multiple sclerosis. Neuroepidemiology 2010; 34: 238-244.
15. McDowell TY, Amr S, Culpepper WJ, et al: Sun exposure, vitamin D and age at disease onset in relapsing multiple sclerosis. Neuroepidemiology 2010; 36: 39-45.
16. Culpepper WJ II, Ehrmantraut M, Wallin MT, Flannery K, Bradham DD: Veterans Health Administration multiple sclerosis surveillance registry: The problem of casefinding from administrative databases. J Rehabil Res Dev 2006; 43: 17-24. (Pubitemid 43938743)
17. Hohol MJ, Orav EJ, Weiner HL: Disease steps in multiple sclerosis: A simple approach to evaluate disease progression. Neurology 1995; 45: 251-255.
18. Schwartz CE, Vollmer T, Lee H: Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group. Neurology 1999; 52: 63-70. (Pubitemid 29044401)
19. Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-871.
20. Woolmore JA, Stone M, Pye EM, et al: Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation. Mult Scler 2007; 13: 369-375. (Pubitemid 46705998)
21. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D: New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13: 100-105. (Pubitemid 36733998)
22. Hauser SL, Oksenberg JR: The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration. Neuron 2006; 52: 61-76. (Pubitemid 44466355)
23. Ascherio A, Munger KL: Environmental risk factors for multiple sclerosis. I. The role of infection. Ann Neurol 2007; 61: 288-299. (Pubitemid 46676728)
24. Thacker EL, Mirzaei F, Ascherio A: Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis. Ann Neurol 2006; 59: 499-503. (Pubitemid 43358070)
25. Edwards S, Zvartau M, Clarke H, Irving W, Blumhardt LD: Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 64: 736-741. (Pubitemid 28274406)
26. Casetta I, Granieri E: Clinical infections and multiple sclerosis: Contribution from analytical epidemiology. J Neurovirol 2000; 6(suppl 2):S147-S151. (Pubitemid 30348929)
27. Lublin FD: Clinical features and diagnosis of multiple sclerosis. Neurol Clin 2005; 23: 1-15. (Pubitemid 40126912)
28. Koch M, Kingwell E, Rieckmann P, Tremlett H: The natural history of primary progressive multiple sclerosis. Neurology 2009; 73: 1996-2002.
29. Vukusic S, Confavreux C: Natural history of multiple sclerosis: Risk factors and prognostic indicators. Curr Opin Neurol 2007; 20: 269-274. (Pubitemid 46743107)
30. Karagas MR, Zens MS, Nelson HH, et al: Measures of cumulative exposure from a standardized sun exposure history questionnaire: A comparison with histologic assessment of solar skin damage. Am J Epidemiol 2007; 165: 719-726. (Pubitemid 46348377)